MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$487,555
Free Cash flow
-$3,966,138
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Change in fair value of warrant ...
Proceeds from issuance of common...
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable and other liabi...
Gain on extinguishment of liabil...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
-
-
27,010
27,222
Cost of revenues
-
-
21,609
21,777
Net revenues
-
-
5,401
5,445
Purchases of property and equipment
0
-
0
0
Net cash from investing activities
0
-
0
0
Research and development expenses
-
-
1,333,102
4,109,782
Commitment fee
0
-
0
150,000
Change in fair value of investment and contingent liability, net
-
-
-
-782,404
Loss on sale of put shares
-
-
-81,828
-182,146
Change in fair value of investment, net
0
-
-273,422
-
Loss on conversion of debt with related parties
0
-
131,135
-
Depreciation and accretion
127,095
142,049
156,940
884,831
Stock-based compensation
1,220
10,019
9,182
205,492
Change in fair value of warrant liability
-
667,343
-
-
Impairment of long-lived asset
-
-
1,500,000
-
Noncash revenue from licensing agreement
0
3,500,000
-
-
Changes in the carrying amount of right-of-use asset
-
-
0
0
Change in fair value of warrant liability
-1,775,992
-
-
-
Accounts receivable
-56,393
42,669
1,508
9,056
General and administrative
-
-
1,499,572
5,796,487
Prepaid expenses and other assets
-9,669
117,883
20,914
-157,747
Other segment items
-
-
-3,546,505
-1,221,883
Accounts payable and other liabilities
-779,506
-1,341,879
-339,231
-362,123
Total operating expenses
-
-
-713,831
8,684,386
Deferred revenue
-121,730
470,000
-
-
Change in fair value of contingent liability
-
-
1,055,826
-
Net loss
-5,219,231
3,472,480
719,232
-4,554,335
Operating lease liability
-
-
0
0
Gain on extinguishment of liability
483,383
-
5,329,911
1
Proceeds from issuance of common stock under sepa, net
-
-
548,152
1,992,779
Net cash used in operating activities
-3,966,138
-1,575,226
-3,355,517
-3,239,941
Proceeds from the issuance and exercise of pre-funded warrants
-
1,500,000
0
0
Proceeds from common stock warrants
-
-
0
-
Proceeds from issuance of debt
0
-
0
0
Proceeds from issuance of common stock
546,861
-
4,017,147
0
Proceeds from issuance of common stock warrants and pre-funded warrants, net
4,953,139
-
-
-
Issuance costs for common stock
38,031
-
321,380
63,500
Issuance costs for common stock warrants and pre-funded warrants
450,548
389,056
-
-
Debt repayment
-32,838
-259,303
-32,847
-31,391
Net cash provided by financing activities
3,478,583
851,641
4,211,072
1,897,888
Net decrease in cash and cash equivalents
-487,555
-723,585
855,555
-1,342,053
Cash and cash equivalents at the beginning of the period
1,228,879
1,952,464
1,096,909
4,674,572
Cash and cash equivalents at the end of the period
741,324
1,228,879
1,952,464
1,096,909
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
HCWB Cash Flow Sankey Diagram
Sankey diagram visualizing HCWB cash flow for the period
Proceeds from issuance of
common stock warrants...
$4,953,139
Proceeds from issuance of
common stock
$546,861
(-62.95%↓ Y/Y)
Net cash provided by
financing activities
$3,478,583
(-23.72%↓ Y/Y)
Canceled cashflow
$2,021,417
Net decrease in cash
and cash...
-$487,555
(78.19%↑ Y/Y)
Canceled cashflow
$3,478,583
Change in fair value of
warrant liability
-$1,775,992
something is missing
$667,343
Depreciation and accretion
$127,095
(-82.12%↓ Y/Y)
Accounts receivable
-$56,393
(89.94%↑ Y/Y)
Prepaid expenses and
other assets
-$9,669
(-87.53%↓ Y/Y)
Stock-based compensation
$1,220
(-99.78%↓ Y/Y)
something is missing
-$1,500,000
Issuance costs for common
stock warrants and...
$450,548
Issuance costs for common
stock
$38,031
(-95.39%↓ Y/Y)
Debt repayment
-$32,838
(48.19%↑ Y/Y)
Net cash used in
operating activities
-$3,966,138
(41.64%↑ Y/Y)
Canceled cashflow
$2,637,712
Net loss
-$5,219,231
(-26.54%↓ Y/Y)
Accounts payable and
other liabilities
-$779,506
(71.88%↑ Y/Y)
Gain on
extinguishment of liability
$483,383
(268.62%↑ Y/Y)
Deferred revenue
-$121,730
Buy us a coffee
HCW Biologics Inc. (HCWB)
HCW Biologics Inc. (HCWB)